Article Details
Retrieved on: 2021-01-05 07:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 15,461,477 shares of the biopharmaceutical company's stock valued at $33,705,000 after purchasing an additional ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here